UNIVERSITY OF CINCINNATI

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1819-01-01

Employees: 5.9K

Market Cap: -

Website: https://www.uc.edu/

Clinical Trials

Monitoring of Biopsy-Proven Interstitial Polyomavirus Nephritis in Kidney and Kidney Pancreas Transplant Recipients

Completed

Conditions: Polyomavirus

First Posted Date: 2006-09-11

Last Posted Date: 2008-01-03

Lead Sponsor: University of Cincinnati

Target Recruit Count: 40

Registration Number: NCT00374283

Locations: 🇺🇸
University of Cincinnati, Cincinnati, Ohio, United States
🇺🇸
The Christ Hospital, Cincinnati, Ohio, United States

A Trial of Two Daclizumab Dosing Strategies vs. No Induction Treatment With Tacrolimus, Mycophenolate Mofetil , & Steroids for the Prevention of Acute Allograft Rejection in Simultaneous Kidney/Pancreas Transplant Recipients

Phase 4

Completed

Conditions: Acute Allograft Rejection in Simultaneous Kidney/Pancreas Transplant Recipients

Interventions: Drug: Daclizumab

First Posted Date: 2006-08-15

Last Posted Date: 2013-10-25

Lead Sponsor: University of Cincinnati

Target Recruit Count: 298

Registration Number: NCT00363116

Locations: 🇺🇸
Cornell University, Ithaca, New York, United States
🇺🇸
University of Tennessee, Memphis, Tennessee, United States
🇺🇸
University of Wisconsin, Madison, Wisconsin, United States

and more 21 locations

Use of Focalin for Fatigue in Sarcoidosis

Phase 4

Completed

Conditions: Sarcoidosis

First Posted Date: 2006-08-08

Last Posted Date: 2011-02-24

Lead Sponsor: University of Cincinnati

Target Recruit Count: 12

Registration Number: NCT00361387

Locations: 🇺🇸
University of Cincinnati Medical Center, Cincinnati, Ohio, United States

Pilot Study for HLA Identical Living Donor Renal Transplant Recipients

Phase 4

Completed

Conditions: Renal Transplant

First Posted Date: 2006-07-14

Last Posted Date: 2014-11-13

Lead Sponsor: University of Cincinnati

Target Recruit Count: 20

Registration Number: NCT00352092

Locations: 🇺🇸
University of Cincinnati, Cincinnati, Ohio, United States

Results of Ocular Compression and Suture Release in Trabeculectomy and Combined Surgery

Completed

Conditions: Primary Open Angle Glaucoma

First Posted Date: 2006-05-18

Last Posted Date: 2006-05-18

Lead Sponsor: University of Cincinnati

Registration Number: NCT00327405

Locations: 🇺🇸
Cincinnati Eye Institute, Cincinnati, Ohio, United States

Use of Thalidomide in Chronic Uveitis

Phase 4

Terminated

Conditions: Uveitis

First Posted Date: 2006-04-14

Last Posted Date: 2007-12-06

Lead Sponsor: University of Cincinnati

Target Recruit Count: 15

Registration Number: NCT00314665

Locations: 🇺🇸
University of Cincinnati Medical Center, Cincinnati, Ohio, United States

Study to Determine the Effectiveness of Pillar Palatal Implants to Treat Obstructive Sleep Apnea

Phase 4

Completed

Conditions: Obstructive Sleep Apnea

First Posted Date: 2006-03-28

Last Posted Date: 2007-12-12

Lead Sponsor: University of Cincinnati

Target Recruit Count: 100

Registration Number: NCT00307957

Locations: 🇺🇸
University Ear, Nose and Throat Specialists, Cincinnati, Ohio, United States
🇺🇸
University of Indiana Medical Center, Indianapolis, Indiana, United States
🇺🇸
Department of OTO-HNS Medical College of Wisconsin, Milwaukee, Wisconsin, United States

Study of Pantoprazole for Sleepiness Associated With Acid Reflux and Sleep Apnea

Phase 4

Completed

Conditions: Acid Reflux Disease
Obstructive Sleep Apnea

First Posted Date: 2006-03-28

Last Posted Date: 2007-12-12

Lead Sponsor: University of Cincinnati

Target Recruit Count: 68

Registration Number: NCT00307944

Locations: 🇺🇸
University Ear, Nose and Throat Specialists, Cincinnati, Ohio, United States

Trial of Magnesium Sulfate Tocolysis Versus Nifedipine Tocolysis in Women With Preterm Labor

Not Applicable

Terminated

Conditions: Premature Birth
Premature Labor

Interventions: Drug: Oral Nifedipine or placebo
Drug: Magnesium sulfate

First Posted Date: 2006-03-23

Last Posted Date: 2009-11-09

Lead Sponsor: University of Cincinnati

Target Recruit Count: 33

Registration Number: NCT00306462

Locations: 🇺🇸
University Hospital, Cincinnati, Ohio, United States

Attention Deficit Hyperactivity Disorder (ADHD) in Adolescents With Substance Use Disorders (SUD)

Phase 3

Completed

Conditions: ADHD
Substance Abuse

Interventions: Drug: Methylphenidate (OROS-MPH)
Drug: Methylphenidate (OROS-MPH) - Placebo

First Posted Date: 2005-12-13

Last Posted Date: 2013-06-07

Lead Sponsor: University of Cincinnati

Target Recruit Count: 303

Registration Number: NCT00264797

Locations: 🇺🇸
Gateway Community Services, Jacksonville, Florida, United States
🇺🇸
St. Luke's-Roosevelt Hospital, Child and Family Institute, New York City, New York, United States
🇺🇸
SSTAR of Rhode Island, North Kingstown, Rhode Island, United States

and more 9 locations

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy